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There are a large number of commercially available milk
formulae labelled as “hypoallergenic”. However, only a
minority of these comply with the criteria established in
the guidelines of Subcommittee on Nutrition and Aller-
gic Disease of the American Academy of Pediatrics.
As far as the treatment of cow’s milk allergy is con-
cerned, the extensive hydrolysed protein formulae and
aminoacid-based formulae are the only two preparations
that meet the standards required for hypoallergenicity,
defined as absence of reactions in 90% allergic patients
with 95% confidence. However, even in these cases
there is great variability in the content of the extensive
hydrolysed formulas on the market and, for some of
them, the clinical data in support of the claim of hypoal-
lergenicity are missing. In addition, other products
known as “partially hydrolysed formulae” have pre-
viously been advertised as being safe for cow’sm i l k
allergic patients but turned out to be inadequate and
responsible for anaphylactic reactions in many cases.
These data underline the fact that it is mandatory to
define the criteria in terms of peptidic content and pre-
clinical profile of any formula put on the market as
hypoallergenic formula for treatment of cow’sm i l k
allergy.
I nt h ec a s eo fp r e v e n t i o no fc o w ’s milk allergy, the
data currently available are incomplete since no study
has yet been published that meets all the criteria recom-
mended by the American Academy of Pediatrics. None-
theless, the studies conducted to date seem to indicate a
greater efficacy of extensive hydrolysed protein formulae
over partially hydrolysed formulae, although the latter
may present nutritional advantages and lower cost.
In conclusion, further efforts are required in the char-
acterisation of the commercially available milk formulae
used for treatment and prevention of cow’s milk allergy.
In the absence of well-documented studies proving the
prophylactic value of partially hydrolysed formulae, chil-
dren at high risk of atopy should be fed with a prophy-
lactic hypoallergenic diet based on extensive hydrolysed
formulas.
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